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Figure 1 
8003 enrolled 
8003 randomized 
2668 assigned continuous oxygen 2667 assigned nocturnal oxygen 2668 assigned control 
 Assessed at 7 days (n= 2651) 
  Lost to follow-up (n= 1) 
  Withdrawn (n= 16) 
  Reasons given for withdrawal: 
- withdrawn consent (n=9) 
- patient did not like treatment (n=5) 
- did not state reason (n=1) 
- other (n=1) 
 Assessed at 7 days (n= 2646) 
  Lost to follow-up (n= 1) 
  Withdrawn (n=20) 
  Reasons given for withdrawal: 
- withdrawn consent (n=8) 
- patient did not like treatment (n=4) 
- did not state reason (n=1) 
- other (n=7) 
 Assessed at 7 days (n= 2664) 
  Lost to follow-up (n= 0) 
  Withdrawn (n=4) 
  Reasons given for withdrawal: 
- withdrawn consent (n=2) 
- patient did not like treatment (n=0) 
- did not state reason (n=1) 
- other (n=1) 
 Assessed at 90 days (n= 2576) 
  Lost to follow-up (n= 35) 
  Withdrew from follow-up  (n=40)            
  Reasons given for withdrawal: 
- withdrawn consent (n=25) 
- patient did not like treatment (n=0) 
- patient left country (n=0) 
- did not state reason (n=5) 
- not a stroke (n=3) 
- patient not well (n=4) 
- other (n=3) 
 Assessed at 90 days (n= 2576) 
  Lost to follow-up (n= 27) 
  Withdrew from follow-up  (n=43) 
  Reasons given for withdrawal: 
- withdrawn consent (n=26) 
- patient did not like treatment (n=1) 
- patient left country (n=1) 
- did not state reason (n=5) 
- not a stroke (n=2) 
- patient not well (n=5) 
- other (n=3) 
 Assessed at 90 days (n= 2567) 
  Lost to follow-up (n= 44) 
  Withdrew from follow-up  (n=53) 
  Reasons given for withdrawal: 
- withdrawn consent (n=23) 
- patient did not like treatment (n=0) 
- patient left country (n=0) 
- did not state reason (n=8) 
- not a stroke (n=5) 
- patient not well (n=3) 
- other (n=14) 
 Included in the analysis of the primary 
outcome (n=2561) 
 
Missing data for primary outcome (n=15) 
 
 
   
Included in the analysis of the primary 
outcome (n=2549) 
 
 Missing data for primary outcome (n=18) 
 
 Included in the analysis of the primary 
outcome (n=2567) 
 
Missing data for primary outcome (n=9) 
   
 
 
